Listed

IGC Pharma, Inc.: Form 10-Q/A for the period ended Jun 30, 2012

Filed with the SEC on Aug 21, 2012 and accepted by EDGAR at Aug 21, 2012, 13:51 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2012-04-01 to 2012-06-30$1.3mus-gaap:Revenues
Cost of revenue3 months2012-04-01 to 2012-06-30$937.4kus-gaap:CostOfRevenue
Selling, general and administrative3 months2012-04-01 to 2012-06-30$440.8kus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2012-04-01 to 2012-06-30−$194.1kus-gaap:OperatingIncomeLoss
Interest expense3 months2012-04-01 to 2012-06-30$10.6kus-gaap:InterestExpense
Income tax3 months2012-04-01 to 2012-06-30−$31.7kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2012-04-01 to 2012-06-30−$528.3kus-gaap:NetIncomeLoss
Diluted EPS3 months2012-04-01 to 2012-06-30−$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2012-04-01 to 2012-06-30−$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2012-04-01 to 2012-06-3039,059,336 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2012-04-01 to 2012-06-30−$80.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2012-04-01 to 2012-06-30$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-06-30$719.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-06-30$5.2mus-gaap:AssetsCurrent
Total assetsAt period end2012-06-30$24.8mus-gaap:Assets
Current liabilitiesAt period end2012-06-30$4.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-06-30$9.4mus-gaap:Liabilities
Short-term borrowingsAt period end2012-06-30$200.8kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2012-06-30$14.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-12-001906. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.